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Abstract: A retrospective analysis was performed to detect anti-rickettsial antibodies in 
the serum of patients with hypertransaminemia of unknown etiology, and in that of healthy 
members of the general population of Madrid (Spain). Among 143 patients 16 (11.2%) 
were positive for anti-R. conorii IgG antibodies and 7% for R. typhi. PCR analysis was 
performed in patients with IgM antibodies. Among 143 healthy subjects from the general 
population, seven (4.9%) were positive for anti-R. conorii IgG antibodies, and 2.8% for R. 
typhi. These results show that anti-rickettsial antibodies are more commonly detected in 
patients with hypertransaminemia than in healthy people.  
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1. Introduction  
 
In recent years, the prevalence of infections with some of the species of rickettsia known to cause 
human disease has been increasing, and new rickettsial species causing human illness have been   
OPEN ACCESSInt. J. Environ. Res. Public Health 2009, 6          
 
 
2527
found [1]. Further, long-known rickettsia of undetermined pathogenicity have now been associated 
with disease. Several factors may be responsible for the emerging status of these infections, including 
climate and ecological changes [2] causing animal reservoirs to move from their original habitats and 
come into closer contact with pets - and therefore with humans. Changes in human demographics and 
the boom in outdoor activities in developed countries may also have led to greater exposure of humans 
to arthropod vectors.  
The diseases caused by rickettsia vary from mild to severe in their presentation, with fatality 
ranging from 0 to over 30%. Infection with any member of the spotted fever (SFG) or typhus group 
(TG) usually involves fever and exanthema and is commonly associated with some liver dysfunction 
which in rare cases can be severe [3,4]. The symptoms of the emerging rickettsioses appear not to be 
so typical, which renders them difficult to diagnose (a problem that may well lead to underdiagnosis) [5], 
but even these infections are commonly associated with liver dysfunction. 
The aim of the present work was to improve our knowledge of rickettsial infections in Spain. Over the 
last few years the country has seen an increase in their incidence; indeed, new rickettsial pathogens 
such as R. felis [6] have been discovered, and new diseases as such as DEBONEL/TIBOLA have been 
recognized [7]. In this work, the seroprevalence of anti-rickettsial antibodies in patients with liver 
dysfunction, identified by high transaminase levels, was measured and compared to that seen in   
healthy subjects.  
 
2. Patients and Methods 
 
Serum specimens: Serum was collected from 143 patients (patient group; 101 males, 42 females; 
age range 1–103 years, mean 43.8 years, standard deviation [SD] 18.3 years) with hypertransaminemia 
(serum aspartate aminotransferase [AST] > 38 U/L and/or alanine aminotransferase [ALT] > 35 U/L; 
see Table 1).  
 
Table 1. Patient ALT and AST levels. 
  Patients n (%)  Mean  Range 
ALT >35 U/L  112 (78.3)  97.4  36-2150 
AST >38 U/L  57 (39.8)  91.3  39-1480 
49 patients (34.2%) had high ALT and AST levels. 
 
Patients with known hepatic viral infections, who were alcoholic, or who were undergoing 
treatment with hepatotoxic drugs, were excluded. The selected patients were under clinical study for 
different reasons: 99 for known hypertransaminemia of indeterminate origin without other clinical 
manifestations, three for acute hepatitis, six for fever, 13 for chronic liver disease, two for 
thrombocytopenia, and three for fatigue and weakness. The rest had come for a routine check-up of 
their health.  
Serum was also collected from 143 members of the general population (control group; 101 males, 
42 females; age range 1–99 years, mean 41.3 years, SD 18.88 years) with normal ALT and AST Int. J. Environ. Res. Public Health 2009, 6          
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values. These subjects came from the same geographical region as the patients (Figure 1) (i.e., Health 
Area 3 of the Madrid Region, which is home to the Príncipe de Asturias University Hospital). 
 
Figure 1. The geographical area of the study. 
 
The medical history and occupation of the patients and controls, their area of residence, travel 
history, and their history of contact with animals and arthropod bites were all recorded. All serum 
samples were maintained at −20 C until analysis. All subjects gave their informed consent to be 
included in the study in compliance with the ethical standards of the Human Experimentation 
Committee of the University of Alcalá de Henares and the Helsinki Declaration of 1964 (as revised  
in 2004). 
Serological tests: Sample sera were analyzed using the indirect immunofluorescence assay (IFA) 
described by Phillip et al. [8]. Rickettsia conorii (strain Malish 7) and R. typhi (strain Wilmington) were 
used as antigens. These were propagated in Vero E6 cells (ATCC CRL 1586) and fixed on spot slides. The 
fluorescein-labeled conjugates used were rabbit anti-human IgG and rabbit anti-human IgM serum (Sigma, 
St Louis, MO), diluted 1/128 in PBS containing Evan’s blue. Briefly, two-fold dilutions of each serum 
sample were added to the antigen spots and incubated in a humidity chamber for 30 min at 37 C. 
After washing, the conjugates were added to each. The slides were then incubated for 30 min, washed, 
and examined using a BH2 Olympus fluorescence microscope (10 × 40). Positive and negative control 
sera were also examined; spots of uninfected Vero E6 cells were used to provide negative control 
antigens. Sera showing a typical pattern of fluorescence at titers of 1:128 for IgG and of 1:64 for IgM 
were deemed positive.  
 
3. Molecular Methods 
 
DNA was extracted from the serum of IgM-positive patients using the COBAS AmpliPrep
® system 
(Roche Diagnostics, GmbH, Mannheim, Germany) according to the manufacturer’s recommendations. 
Nested PCR assays targeting the rickettsial genes for citrate synthase (gltA) [9]
 using the primers 
CS415/CS1220 and RpCs1258/Rp877 that amplify a 381-bp fragment, and 190-kDa protein (ompA) Int. J. Environ. Res. Public Health 2009, 6          
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gene [9,10] using Rr190.70p /Rr 190.602n and FW1/RV2 primers which amplifying a 492-bp 
fragment. To prevent DNA contamination and the carry-over of amplified products, sterile tools were 
used at all times in each step of the analysis (DNA extraction, preparation of the reaction mixture, and 
amplification and analysis of the PCR products); each step was performed in separate work areas. A 
negative control (Milli-Q water) was included all amplifications.  
Statistical analysis: The differences in proportions in 2-way tables were analyzed using the 
2 or 
Fisher exact test. Significance was set at <0.05.  
 
4. Results 
 
Sixteen patients with hypertransaminemia (total 11.2%; females 4.8%, males 14%) had IgG 
antibodies for R. conorii. The age of the seropositive subjects ranged from 25 to 81 years (mean 50 
years, SD 13.3 years). Ten patients with hypertransaminemia (total 7%; females 9.5%, males 5.9%) 
had IgG antibodies for R. typhi. The age of these seropositive subjects ranged from 1 to 68 years (mean 
35 years, SD 17.6 years). Two patients were shown to have antibodies to both rickettsial species. No 
difference was noted in prevalence of infection in the rural and urban areas (13% vs. 9% for R. conorii, 
and 9.2% vs. 4.5% for R. typhi ). Among the patients, no significant differences were found in 
seroprevalence with respect to sex or age. 
Table 2 shows the clinical blood test results for all the seropositive patients (13 patients came to the 
clinic for known hypertransaminemia, one for fever, one for lymphocytosis, one for abdominal 
exanthema, one for abdominal pain, and the remainder for a routine check-up), and the patient media 
values and range of transaminase levels were 110.2 U/l and 90-2150 U/l for ALT and 107.7 U/l and 
97-1480 U/l for AST respectively.  
 
Table 2. Analytical abnormalities in seropositive patients. 
Clinical findings  R. conorii 
N (%) 
R. typhi 
N (%) 
Lymphocytosis  4 (25%)  5 (50%) 
Lymphopenia  3 (18.7%)  2 (20%) 
Thrombocytopenia 2  (12.5%)  - 
Hyperbilirubinemia  4 (25%)  2 (20%) 
Elevated alkaline phosphatase   4 (25%)  4 (40%) 
Elevated GGT   4 (25%)  2 (20%) 
Elevated lactate dehydrogenase  3 (18.7%)  2 (20%) 
 
Four of the seropositive patients were immigrants. One of the patients referred to contact with cats; 
another was homeless. The remaining subjects had no history of contact with animals or arthropod 
bites, and had no occupational risks.  
Only two patients were positive for IgM antibodies (also they had IgG antibodies): one for R. 
conorii antibodies (that of a 59 year-old man with abdominal pain, lymphopenia, hyperbilirubinemia, 
and elevated phosphatase alkaline [FA], lactate dehydrogenase [LDH] and gamma-glutamyl Int. J. Environ. Res. Public Health 2009, 6          
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transferase [GGT]); the other for R. typhi antibodies (that of a 27 year-old man with elevated GGT). 
The molecular assay, however, did not detect rickettsial DNA.  
In the control group, IgG antibodies to R. conorii were found in seven serum samples (total 4.9%; 
females 7.1%, males 4%). The mean age of these subjects was 55 years (SD 15 years; range   
32–81 years). IgG antibodies to R. typhi were found in four serum samples (total 2.8%; females 4.7% 
and males 2%). The mean age of these subjects was 39 years (SD 16 years; range 19–86 years). One 
sample contained antibodies to both rickettsial species. Again, no difference was seen in prevalence of 
infection between the rural and urban areas (6.6% vs. 3% for R. conorii infection, and 4% vs. 1.5% for 
R. typhi infection) and respect to sex or age. The seropositive subjects had no history of contact with 
animals or arthropod bites, and had no occupational risks.  
The prevalence of seropositivity for R. conorii in the patient and control groups was significantly 
different (p < 0.05; 
2 = 3.84), with more positive results among the patients. Table 3 shows the titers 
of IgG antibodies for the seropositive subjects. 
 
Table 3. Titers for antibodies (IgG) to R. conorii and R. typhi. 
Groups 
Titer 
1/128 
Titer 
1/256 
Titer 
1/512 
Titer 
1/1024 
Titer 
1/2048 
Patient with 
Ab-R. conorii 
6 (4.2%)  5 (3.5%)  5 (3.5%)  -  - 
Patient with 
Ab-R. typhi 
3 (2.1%)  4 (2.8%)  2 (1.2%)  -  1 (0.7%) 
 
Control population 
with Ab-R. conorii 
3 (2.1%)  -  4 (2.8%)  -  - 
Control population 
with Ab-R. typhi 
2 (1.2%)  1 (0.7%)  1 (0.7%)  -  - 
 
4. Discussion 
 
The rickettsia have a universal distribution, but our knowledge on the epidemiology of these organisms 
and their health impacts differs according to geographical region. These bacteria are associated with 
emerging diseases, and those associated with new rickettsial species are currently being   
investigated [11]. The spectrum of illness caused by rickettsia is very wide and the symptoms of 
infection in different areas may vary from those of classic SFG and TG infections. However, hepatic 
manifestations have been well described not only in SFG [3,12-16] and TG [4,5,17]
 infections, but also 
in clinical cases caused by emergent strains [7,18]. Liver damage is manifested as   
transaminase elevation and biological signs of cholostasis. Hepatic granulomas are also characteristic 
of infection [19] and rickettsiosis should be considered in the differential diagnosis of hepatitis [20]. 
When a rickettsial infection is suspected, liver function tests should always be performed. Some 
infections, however, may remain hepatically silent [15]. 
Emerging diseases caused by new strains of rickettsia have been recorded in Spain, including 
DEBONEL/TIBOLA caused by R. slovaca [7]
 and a typhus like fever caused by R. felis [21]. Further, Int. J. Environ. Res. Public Health 2009, 6          
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the number of clinical SFG and TG infections has increased over the last few years in this country [22-24]. 
Studies in the general population, mainly for SFG, have tried to determine the circulating strains involved 
using molecular techniques, and to isolate them in animal reservoirs and vectors. Studies have also been 
undertaken to characterize the clinical manifestations of infection by emergent species.  
The aim of the present study was to determine the prevalence of rickettsial infection among patients 
with liver dysfunction, and to determine whether there were differences that seen in the general 
population. Only two antigens (one SFG and one TG) were used since the different species of 
rickettsia show high levels of cross reactivity [25] (reducing the chance of missing any positive result). 
The results confirm the presence of SFG and TG infection in the study zone. The rate for both TG- and 
SFG-type infection in the general population was lower than that reported recently from other areas 
from Spain, e.g., prevalences of antibodies to R. conorii of 8% [26] and to R. typhi of 3.7% [27] have 
been reported from the northeast, and of 8.7% for R. conorii [28]
 and 3.8% for R. typhi [28]
 from the 
south. Similar figures are reported from Greece [29] (prevalence for R. conorii 7.9% and for R. typhi 
2%, and most North African [30] countries (5–8% for R. conorii and 0.5–4% for R. typhi).  
The present results showed no differences in prevalence according to sex, age, or origin (rural vs. 
urban). To date, R. conorii infection has more commonly been reported in rural areas, and R. typhi in 
urban areas. However, in recent years, studies in Spain [27] and in other places have reported this 
situation to be changing. This may be due to alterations in human demographics and behavior 
(movement to semi-rural areas, more outdoor activities) leading to more contact between wild animals 
and humans and their pets.  
The results show that in the study area the patients with hypertransaminemia more commonly 
possessed antibodies to rickettsia than the members of the control group. The patients showed a higher 
prevalence of both SFG and TG infection, and their antibody titers were higher. Anti-rickettsial IgM 
antibodies were also detected in two patients, although they had no recent history of illness compatible 
with classical rickettsial infection and no rickettsial DNA was detected in their serum. One year later, 
seventeen patients saw their transaminase levels normalize and two continued with high levels of 
ALT; five patients did not keep further appointments and were lost to analysis. 
This is the first time that the prevalence of rickettsial infection among patients with impaired liver 
function has been examined, and the data obtained seem to indicate that the present group could have 
greater contact with these organisms. It may therefore be appropriate to screen for rickettsia in such 
patients, even though they do not present all the signs and symptoms characteristic of rickettsiosisal, 
because the list of newly discovered rickettsiae has grown rapidly in recent years and the clinical 
manifestations of these infections may be atypicals. However, it is important to mention that there are 
cross-reaction with other conditions, for example autoimmune hepatitis, therefore other serological 
studies with more specific assays are planned to further confirm the prevalence of rickettsial-
antibodies among patients with liver dysfunction with the aim to avoid false positives.  
In summary, rickettsioses are emerging diseases in Spain. Large-scale epidemiological surveillance 
is therefore needed, and clinical data should be diligently collected in order to help in the diagnosis  
of infection.  
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